genomics and personalized healthcare lecture 2

28
Genomics and Personalized Healthcare Lecture 2 Bailee Ludwig Quality Management

Upload: argyle

Post on 25-Feb-2016

44 views

Category:

Documents


3 download

DESCRIPTION

Genomics and Personalized Healthcare Lecture 2. Bailee Ludwig Quality Management. Outline. The Human Genome Project Quality & Safety Genomic Ethics Genetic Law Risk Perception and Health Behavior Scenarios. The Human Genome Project. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Genomics and Personalized Healthcare Lecture 2

Genomics and Personalized HealthcareLecture 2

Bailee LudwigQuality Management

Page 2: Genomics and Personalized Healthcare Lecture 2

Outline

–The Human Genome Project–Quality & Safety

–Genomic Ethics

–Genetic Law

–Risk Perception and Health Behavior–Scenarios

Page 3: Genomics and Personalized Healthcare Lecture 2

The Human Genome Project• In the pre-module survey, a lot of you asked

about the HGP….

“The Human Genome Project (HGP)[is]an international research effort to sequence and map all of the genes - together known as the genome - of members of our species, Homo sapiens. Completed in April 2003, the HGP gave us the ability to, for the first time, to read nature's complete genetic blueprint for building a human being.”

Page 4: Genomics and Personalized Healthcare Lecture 2

HGP Facts• The two genomes of any two people are 99% the

same• The HGP has already aided in the discovery of more

than 1,800 disease genes.• Today’s researchers can find a gene suspected of

causing an inherited disease in a matter of days, rather than the years it took before

• There are now more than 1,000 genetic tests for human conditions– Risk and Diagnosis

Page 5: Genomics and Personalized Healthcare Lecture 2

Predicted Benefits of the HGP

• Personalized medicine– Drugs that work catered to our genetic

makeup, at your speed, with less side effects• Personalized Disease Detection

– Detecting and Preventing disease with your genome

– At least 350 biotechnology-based products resulting from the Human Genome Project are currently in clinical trials.

Page 6: Genomics and Personalized Healthcare Lecture 2
Page 7: Genomics and Personalized Healthcare Lecture 2

How accessible can a person’s genome really be?

According to the National Human Genome Research Institute…

…by 2014 sequencing a human genome could be as cheap as $1,000

Page 8: Genomics and Personalized Healthcare Lecture 2

With a sequencing a genome so accessible..it will lead to some amazing possibilities…

…but there is also some risk we need to examine

Page 9: Genomics and Personalized Healthcare Lecture 2

Quality & Safety in Genomics

Page 10: Genomics and Personalized Healthcare Lecture 2

Quality Issues

According to the World Health Organization (WHO) …– Laboratory regulation and accreditation

measures have not kept pace with the growing demand for genetic tests

– The accuracy of complicated laboratory tests should be met with appropriate quality control guidelines

Page 11: Genomics and Personalized Healthcare Lecture 2

Safety

• Patient safety – Assuring informed consent

– Protecting genetic information

– Protecting patients from unjust discrimination

Page 12: Genomics and Personalized Healthcare Lecture 2

Informed Consent“Before an individual agrees to participate in a clinical trial,

research project or undergo a genetic test, he or she must be informed of the test's purpose, medical implications, alternatives, and possible risks and benefits. Patients should additionally be made aware of their privacy rights, including where their DNA will be stored and who will have access to their personal information.

• An informed consent document, requiring the patient's signature, should articulate all of these details. Even after signing, the patient may still opt out of the test or study; the informed consent document is not a contract

Genome.Gov

Page 13: Genomics and Personalized Healthcare Lecture 2

Quality

• Setting standards

• Evaluating performance

• Monitoring outcomes of service– Counseling must be administered to inform the

patient of the range of options and possible outcomes

Page 14: Genomics and Personalized Healthcare Lecture 2

Why…?

…. Safety & Quality measures need to be developed concurrently with advances in genetic testing in order to protect patients from misinformation, and avoidable harm

http://www.who.int/genomics/en/

Page 15: Genomics and Personalized Healthcare Lecture 2

“I understand and agree that any specimens or tissues normally removed from my body by VUMC in the course of any diagnostic procedures, surgery, or medical treatment that would otherwise be disposed of may be retained, used for educational purposes or research, including research on the genetic material (DNA) or other information contained in those tissues or specimens”

Page 16: Genomics and Personalized Healthcare Lecture 2

Genetic Discrimination

• Social Discrimination– Sickle Cell Anemia

• Employer Discrimination– Railroad and Carpal Tunnel Syndrome

• Insurance Discrimination– Fragile X Syndrome as a preexisting

condition”

Page 17: Genomics and Personalized Healthcare Lecture 2

http://www.youtube.com/watch?v=8PYpmKSuwIU

Genetic Discrimination Change Initiative Project

Page 18: Genomics and Personalized Healthcare Lecture 2

Privacy & Antidiscrimination Laws• Title VII of the Civil Rights Act of 1964

– Genetic Diseases associated with particular ethnic or racial groups

• Rehab. Act of 1973 / Americans w/ Disabilities Act of 1990– Doesn’t stop an employer from requiring

employees to provide genetic info.• HIPAA

– Didn’t protect people who chose private coverage• HIPAA Mandate of 2002

Page 19: Genomics and Personalized Healthcare Lecture 2

Genetic Info. Non-Discrimination Act

• Specifically deals with Genetic Info.• Bans insurance companies from denying

health individuals coverage or charging higher premiums

• Prevents employers from using genetic info.

Page 20: Genomics and Personalized Healthcare Lecture 2

http://www.youtube.com/watch?v=z7RbIUmbGsg

Louise Slaughter discusses GINA

Page 21: Genomics and Personalized Healthcare Lecture 2

Medical Ethics• Nonmaleficence – doing no harm

– Preventing unsolicited revelations concerning genetic info.

• Benefcence – doing good– Achieved through the discovery of disease-

related genes and improved treatments• Justice- treating everyone fairly

– Avoiding genetic discrimination or stigmatization

Page 22: Genomics and Personalized Healthcare Lecture 2

Medical Ethics

• Autonomy – respecting the individual’s right to self determination– Preserving your own genetic information

• Utility – doing the most good and the least harm– Duty to warn

Page 23: Genomics and Personalized Healthcare Lecture 2

Let’s read some Duty to Warn Scenarios….

….what would YOU do?

Page 24: Genomics and Personalized Healthcare Lecture 2

Would you want to know…?

Page 25: Genomics and Personalized Healthcare Lecture 2

Risk Perception

• The degree to which a person holds the belief that he or she is likely to develop a disease (actual risk is based on medical and epidemiological data)

• Those actions that are taken to prevent disease

Health Behavior

Page 26: Genomics and Personalized Healthcare Lecture 2
Page 27: Genomics and Personalized Healthcare Lecture 2

Scenarios

• http://www.genome.gov/25019902

Page 28: Genomics and Personalized Healthcare Lecture 2

Discussion Questions